1. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells
   Hyang Ri Kang et al, 2016, Oncology Reports CrossRef
2. Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells
   Lei Huang et al, 2018, Molecular Medicine Reports CrossRef
3. Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells
   Floriana Morgillo et al, 2017, Oncotarget CrossRef
4. Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs
   M. Orditura et al, 2018, The Breast CrossRef
5. Effect of Paclitaxel-loaded Nanoparticles on the Viability of Human Hepatocellular Carcinoma HepG2 Cells
   Zhi-Hong Hou et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
6. Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells
   Sung Hun Bae et al, 2018, Biomolecules & Therapeutics CrossRef
7. Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways
   Christina H. Stuelten et al, 2018, Cellular Signalling CrossRef